Comorbidity and pattern of substance use in hospitalized psychiatric patients

Iranian Red Crescent Medical Journal

Volumn 16, Issue 8, 2014, Pages

  Sepehrmanesh, Zahra ^a   Ahmadvand, Afshin ^a   Moraveji, Alireza ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Comorbidity; Mental disorders; Substance Related disorders

Indexed keywords

AMPHETAMINE; CANNABIS; METHAMPHETAMINE; OPIATE;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG ABUSE PATTERN; FAMILY THERAPY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MOOD DISORDER; PATIENT COUNSELING; PREVALENCE; PSYCHOSIS; SUBSTANCE USE;

EID: 84982199252     PISSN: 20741804     EISSN: 20741812     Source Type: Journal    
DOI: 10.5812/ircmj.19282     Document Type: Article

References (25)

1. Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs. 2002;62(5):743-55.
2. Williams R, Cohen J. Substance use and misuse in psychiatric wards. A model task for clinical governance? Psychiatr Bull. 2000;24(2):43-6.
3. Mueser KT, Yarnold PR, Rosenberg SD, Swett CJ, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull. 2000;26(1):179-92.
4. Siris SG. Pharmacological treatment of substance-abusing schizophrenic patients. Schizophr Bull. 1990;16(1):111-22.
5. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51(4):273-9.
6. Sato M, Numachi Y, Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull. 1992;18(1):115-22.
7. Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010;105(6):1117-28.
8. Turner WM, Tsuang MT. Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull. 1990;16(1):87-95.
9. Le Bec PY, Fatseas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. Encephale. 2009;35(4):377-85.
10. DeQuardo JR, Carpenter CF, Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res. 1994;28(3):267-75.
11. Goswami S, Singh G, Mattoo SK, Basu D. Courses of substance use and schizophrenia in the dual-diagnosis patients: is there a relationship? Indian J Med Sci. 2003;57(8):338-46.
12. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511-8.
13. Baigent M. Managing patients with dual diagnosis in psychiatric practice. Curr Opin Psychiatry. 2012;25(3):201-5.
14. Hosseini SH, Zarghami M, Mousavi SE, Nateghi GHR, Masuod Zadeh A. Study on the simultaneity of the substance abuse with psychiatric disorder in referred of psychiatry clinic of Zare hospital for period of one year. J Mazandaran Univ Med Sci. 2008;18(67):67-74.
15. Ghaleiha A, Zarabian MK, Haghighi M, Bahrami MH. Frequency of substance abuse in hospitalized patients in psychiatric wards of Frshchian hospital in Hamedan. J Hamedan Univ Med Sci. 2010;17(1-55):52-7.
16. Smith SM, Stinson FS, Dawson DA, Goldstein R, Huang B, Grant BF. Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2006;36(7):987-98.
17. Ndetei DM, Pizzo M, Kuria MW, Khasakhala L, Maru MH, Mutiso V. Substance abuse and psychiatric co-morbidities: a case study of patients at Mathari Psychiatric Hospital, Nairobi, Kenya. Afr J Drug Alcohol Stud. 2008;7(1).
18. Rodriguez-Jimenez R, Aragues M, Jimenez-Arriero MA, Ponce G, Munoz A, Bagney A, et al. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics]. Invest Clin. 2008;49(2):195-205.
19. Katz G, Durst R, Shufman E, Bar-Hamburger R, Grunhaus L. Substance abuse in hospitalized psychiatric patients. Isr Med Assoc J. 2008;10(10):672-5.
20. Sinclair JM, Latifi AH, Latifi AW. Co-morbid substance misuse in psychiatric patients: prevalence and association with length of inpatient stay. J Psychopharmacol. 2008;22(1):92-9.
21. Hauli KA, Ndetei DM, Jande MB, Kabangila R. The prevalence of substance use among psychiatric patients: the case study of Bugando Medical centre, Mwanza (northern Tanzania). Subst Abus. 2011;32(4):238-41.
22. Drake RE, Wallach MA, Alverson HS, Mueser KT. Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Ment Dis. 2002;190(2):100-6.
23. Behdani F, Hebrani P. Substance use in schizophrenic patients admitted in Ibn-e Sina Hospital،Mashhad. Q J Fund Ment Health. 2008;10(36):93-70.
24. Ringen PA, Lagerberg TV, Birkenaes AB, Engn J, Faerden A, Jonsdottir H, et al. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychol Med. 2008;38(9):1241-9.
25. Mericle AA, Ta Park VM, Holck P, Arria AM. Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity. Compr Psychiatry. 2012;53(6):657-65